MALONE MARY ALICE
Known title: DirectorCIK: 0001206698
Associated companies
Transaction History
| CPB | ▲ Buy | Grant | 1,055 | $0 | 3/27/2025 | View on chart |
| CPB | ▲ Buy | Grant | 948 | $0 | 12/30/2024 | View on chart |
| CPB | ▲ Buy | Grant | 794 | $0 | 9/26/2024 | View on chart |
| CPB | ▲ Buy | Grant | 860 | $0 | 6/26/2024 | View on chart |
| CPB | ▲ Buy | Grant | 891 | $0 | 3/27/2024 | View on chart |
| CPB | ▲ Buy | Grant | 884 | $0 | 12/28/2023 | View on chart |
| CPB | ▲ Buy | Grant | 921 | $0 | 9/29/2023 | View on chart |
| CPB | ▲ Buy | Grant | 836 | $0 | 6/29/2023 | View on chart |
| CPB | ▲ Buy | Grant | 699 | $0 | 3/30/2023 | View on chart |
| CPB | ▲ Buy | Grant | 637 | $0 | 12/29/2022 | View on chart |
| CPB | ▲ Buy | Grant | 768 | $0 | 9/29/2022 | View on chart |
| CPB | ▲ Buy | Grant | 746 | $0 | 6/29/2022 | View on chart |
| CPB | ▲ Buy | Grant | 819 | $0 | 3/30/2022 | View on chart |
| CPB | ▲ Buy | Grant | 836 | $0 | 12/30/2021 | View on chart |
| CPB | ▲ Buy | Grant | 843 | $0 | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Campbell's Shares Near 52-Week Low Amid Dividend Scrutiny
Recent articles examine Campbell's stock as a potential value trap, noting a 16% decline in September and ongoing pressure on the company's valuation. The stock is currently trading near its 52-week low, with analysts debating whether its 3.6% dividend yield justifies the current price. This context highlights growing skepticism among investors regarding the company's ability to sustain its financial performance.
Campbell's Shares Near 52-Week Low Amid Dividend Scrutiny. Recent articles examine Campbell's stock as a potential value trap, noting a 16% decline in September and ongoing pressure on the company's valuation. The stock is currently trading near its 52-week low, with analysts debating whether its 3.6% dividend yield justifies the current price. This context highlights growing skepticism among investors regarding the company's ability to sustain its financial performance.